Drug Profile
Linetastine
Alternative Names: Linazolast; TMK 688; YM 257Latest Information Update: 22 Nov 2007
Price :
$50
*
At a glance
- Originator Terumo
- Developer Terumo; Yamanouchi
- Class Antiasthmatics
- Mechanism of Action 5-lipoxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic rhinitis; Asthma; Atherosclerosis; Peptic ulcer; Skin cancer; Thrombosis
Most Recent Events
- 01 Dec 1997 Phase-II clinical trials for Allergic rhinitis in USA (Unknown route)
- 12 Sep 1997 A study in patients with allergic perennial rhinitis has been added to the adverse events and Obstructive Airways Disease therapeutic trials sections
- 31 Oct 1996 A preclinical study has been added to the Obstructive Airways Disease pharmacodynamics section